Sentence examples for individualized choices from inspiring English sources

To involve patients in decision making about CHD prevention, we previously developed a decision aid that provides patients with basic information about CHD prevention and encourages patients to make individualized choices about CHD risk reduction.

Adding a genetic component to treatment trials could greatly help to understand the biological basis of variations in the efficacy of therapies and, in the future, could lead to individualized choices of therapy.

The term 'Care Guide' suggests that the document is supposed to guide the health care staff in making individualized choices in caring for dying patients, without being a protocol that has to be followed.

If one supports individualized choice for principle or other reasons [ 27], one could argue that the decision to either obtain as much cytogenetic information as possible versus a rapid but specific result on the most common chromosomal abnormalities is most appropriately made by individuals who will bear the responsibility for raising the child.

Therefore, it is important to individualize choice of dialysis modality.

Perhaps an in-depth study on the immunologic effects, including acute hypersensitivity reactions, for the three enzymes should be performed, so as to identify risk factors that may aid in individualizing choice of therapy.

While Obama didn't address her concerns regarding Thimerosal or individualized health choices when it comes to vaccines, McCain did.

However, practicing a multidimensional geriatric asessment for individualized treatment choice in NSCLC elderly patients is mandatory.

The different animal models of RA may represent unique subtypes and may help us understand disparate clinical responses to better individualize therapeutic choices.

In this systematic review, we find evidence of biologically plausible pharmacogenetic interactions for metformin, sulfonylureas, repaglinide, pioglitazone, rosiglitazone, and acarbose, but these results require confirmation in future studies to determine if an individual's genetic information can be used to individualize the choice of prediabetes and diabetes pharmacologic management.

The results support the current practice of individualizing the choice of an initial vasopressor based on patient profile.